Pharmaceutical industry – Page 51
-
Business
Big data to sniff out drug marketing fraud
US Food and Drug Administration wants to track promotional spending to spot off-label marketing
-
Business
Japanese pharma opens compound vaults
Molecule libraries to be screened for neglected diseases
-
Business
Two new ‘personalised’ cancer drugs approved
Suitable patients for GSK’s melanoma treatments must be identified using an accompanying genetic test
-
CareersSupport from rent-a-lab
As startups flourish and outsourcing increases, Labstract is stepping in to provide space, expertise and training for the new model of R&D, as Yfke Hager learns
-
OpinionCompulsory licences: necessity or threat?
Are compulsory licences for patent-protected drugs a necessary measure, or a threat to innovation?
-
Business
$500m fine over generics fraud for Ranbaxy
Company has pleaded guilty to fabricating data and producing substandard drugs
-
Business
GSK partners Save the Children for Africa project
Company and charity will work together to provide medicines for the developing world
-
BusinessClinical trial data release blocked by companies
Abbvie and Intermune sue the European Medicines Agency to stop it making data public
-
BusinessBuy Viagra online - direct from the manufacturer
Pfizer launches website for mail order erectile dysfunction drug prescriptions
-
Business
AstraZeneca site to become biotech hub
As AZ leaves, Alderley Park will become an incubator for small companies
-
Business
Judge reverses jury decision over $6.5m Takeda payout
Not enough evidence to link diabetes drug to bladder cancer, the company claims
-
Business
Bayer buys Conceptus for $1.1bn
Deal gives German pharma giant access to surgery-free permanent birth control procedure
-
Business
US sues Novartis over alleged kickbacks
Company fraudulently paid pharmacies to switch patients onto its drugs, government claims
-
BusinessIreland picks preferred drugs
Using the cheapest of equivalent options could save healthcare providers millions
-
Business
Objections raised to GSK pay-for-delay deals
The UK Office of Fair Trading believes deals to delay generic drugs infringed competition laws
-
BusinessThermo Fisher to buy Life Technologies in $15.8bn deal
Equipment suppliers unite, bringing Thermo into life sciences and sequencing markets
-
FeatureFrom molecules to medicines
Turning an active drug molecule into a finished product requires as much chemistry as developing the drug in the first place, as Phillip Broadwith discovers
-
Business
Morning sickness drug reintroduced to US
After being withdrawn due to litigation, the drug has been approved by the FDA
-
BusinessIndia rejects Novartis patent appeal
Supreme court uphold decision to refuse protection for Glivec
-
Business
Roche to release Tamiflu trial data
The company will drip feed data to the Cochrane Collaboration, but with some elements redacted